• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Alimentiv Acquires McDougall Scientific

    Q BioMed Inks Strontium89 Supply Pact

    PCI Pharma Services Appoints SVP, CFO

    AbbVie Opts to Acquire Mitokinin

    WuXi AppTec Completes OXGENE Acquisition
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    WuXi AppTec Completes OXGENE Acquisition

    Celonic Group Announces Plans for New Facility in Switzerland

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Alimentiv Acquires McDougall Scientific

    WuXi AppTec Completes OXGENE Acquisition

    Live Webinar - Formulation Strategies for Poorly Soluble Molecules

    Celonic Group Announces Plans for New Facility in Switzerland

    Icon to Acquire PRA Health Sciences
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    Reed-Lane

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Alcami

    Adare Pharma Solutions

    Syngene

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal

    Enter an agreement for a process development partnership.

    Related CONTENT
    • Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
    • Catalent, Trizell Enter Cell Therapy Deal
    • Cognate BioServices Announces Major Expansion
    • Bioclinica Partners with Ikcon Pharma
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Contract Pharma Staff01.19.21
    Bone Therapeutics, a cell therapy company addressing unmet medical needs in orthopedics and other diseases, and Rigenerand SRL, a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology, have signed an agreement for a process development partnership.
     
    Allogeneic mesenchymal stem cell (MSC) therapies are currently being developed at a fast pace and are evaluated in numerous clinical studies covering diverse therapeutic areas such as bone and cartilage conditions, liver, cardiovascular and autoimmune diseases in which MSCs could have a significant positive effect.
     
    “Advances in process development to scale up these therapies could have major impacts for both their approval and commercial viability. This will be essential to bring these therapies to market to benefit patients as quickly as possible,” said Miguel Forte, chief executive officer, Bone Therapeutics. “While Bone Therapeutics is driving on its existing clinical development programs, we have signed a first formal agreement with Rigenerand as a fellow MSC-based organization. This will result in both companies sharing extensive expertise in the process development and manufacturing of MSCs and cell and gene therapy medicinal products. Bone Therapeutics also selected Rigenerand to partner with for their additional experience with wider process development of advanced therapy medicinal products (ATMPs), including the conditioning and editing of MSCs.”
     
    The scope of collaborations between Bone Therapeutics and Rigenerand aims to focus on different aspects of product and process development for Bone Therapeutics’ expanding therapeutic portfolio. Rigenerand will contribute to improving the processes involved in the development and manufacture of Bone Therapeutics’ MSC based allogeneic differentiated cell therapy products as they advance towards patients. The first collaboration between the two organizations will initially focus on augmented professional bone-forming cells—cells that are differentiated and programmed for a specific task. There is also potential for Bone Therapeutics to broaden its therapeutic targets and explore new mechanisms of action with potential gene modifications for its therapeutic portfolio.
     
    In addition to Rigenerand’s MSC expertise, Bone Therapeutics also selected Rigenerand as a partner for Rigenerand’s GMP manufacturing facility. This facility, situated in Modena, Italy, has been designed to host a number of types of development processes for ATMPs. These include somatic, tissue engineered and gene therapy processes. These multiple areas of Rigenerand capabilities enable critical development of new processes and implementation of the gene modification of existing processes. In addition, Rigenerand has built considerable experience in cGMP manufacturing of MSC-based medicinal products, including those that are genetically modified.
     
    “Process development and manufacturing is a key part of the development for ATMPs internationally. Navigating these therapies through the clinical development phase and into the market requires a carefully considered process development pathway,” said Massimo Dominici, scientific founder, Rigenerand, professor of medical oncology, and former president of the International Society for Cell & Gene Therapy (ISCT). “This pathway needs to be flexible, as both the market and materials of these therapies continues to evolve alongside an improved clinical efficacy.”
     
    Giorgio Mari, chief executive officer, Rigenerand, said, “Rigenerand will offer considerable input from its experience of MSC-based therapies to enable Bone Therapeutics to keep and further accelerate the pace in development of the product processes of its MSC based allogeneic differentiated cell therapy as they advance towards patients. We will continue to use our MSC expertise in the development of Rigenerand’s own products, as well as in process development and manufacturing cell and gene therapies for partner organizations across the globe.”
    Suggested For You
    Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
    Catalent, Trizell Enter Cell Therapy Deal Catalent, Trizell Enter Cell Therapy Deal
    Cognate BioServices Announces Major Expansion Cognate BioServices Announces Major Expansion
    Bioclinica Partners with Ikcon Pharma Bioclinica Partners with Ikcon Pharma
    Thermo Fisher Buys Novasep Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Precision Medicine Group Acquires Project Farma Precision Medicine Group Acquires Project Farma
    RheinCell Therapeutics Achieves GMP Certification RheinCell Therapeutics Achieves GMP Certification
    Cyclolab and EpiPharma Form Joint Venture Cyclolab and EpiPharma Form Joint Venture
    Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals
    Innocare Gets Approval from NMPA for Orelabrutinib Innocare Gets Approval from NMPA for Orelabrutinib
    Fujifilm to Invest $2B in US Manufacturing Site Fujifilm to Invest $2B in US Manufacturing Site
    Clinical & Translational Biomarkers Clinical & Translational Biomarkers
    Management of Chronic Diseases with Medical Sensors and Wearables Management of Chronic Diseases with Medical Sensors and Wearables
    Monitoring Visit Reports for Medical Device Studies Monitoring Visit Reports for Medical Device Studies
    Structural Characterization of Biologics Using High-Resolution Mass Spectrometry Structural Characterization of Biologics Using High-Resolution Mass Spectrometry

    Related Breaking News

    • Breaking News | Clinical Trials | CRO News | Information Technology
      Alimentiv Acquires McDougall Scientific

      Alimentiv Acquires McDougall Scientific

      Niche CRO specializes in statistical analysis, data management, reporting, and clinical trial design.
      Kristin Brooks 03.02.21

    • Breaking News | Industry News
      Q BioMed Inks Strontium89 Supply Pact

      Q BioMed Inks Strontium89 Supply Pact

      Agreement provides U.S. veterans and other federal government agencies access to Strontium89 for metastatic bone pain.
      Kristin Brooks 03.02.21

    • Breaking News | Promotions & Moves
      PCI Pharma Services Appoints SVP, CFO

      PCI Pharma Services Appoints SVP, CFO

      Tom De Weerdt brings more than 20 years of experience in financial leadership roles at large, global corporations.
      Kristin Brooks 03.02.21


    • Breaking News | Industry News
      AbbVie Opts to Acquire Mitokinin

      AbbVie Opts to Acquire Mitokinin

      Following completion of IND enabling studies on Mitokinin's lead PINK1 compound for Parkinson's disease.
      Kristin Brooks 03.02.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
      WuXi AppTec Completes OXGENE Acquisition

      WuXi AppTec Completes OXGENE Acquisition

      Expands Cell and Gene Therapy service offerings for global customers.
      Kristin Brooks 03.02.21

    • Breaking News | Promotions & Moves
      Romaco Names Sales Directors in Cologne, Bologna and Karlsruhe

      Romaco Names Sales Directors in Cologne, Bologna and Karlsruhe

      Borja Guerra, Massimiliano Cesarini and Ralph Augenstein join the sales and service teams.
      Kristin Brooks 03.02.21


    • Breaking News | Promotions & Moves
      Impel NeuroPharma Expands Commercial Team

      Impel NeuroPharma Expands Commercial Team

      Prepares for the potential launch of TRUDHESA for the acute treatment of migraine headaches, pending FDA approval.
      Kristin Brooks 03.02.21

    • Breaking News | Industry News
      J&J’s Single-Dose COVID-19 Vax Issued EUA

      J&J’s Single-Dose COVID-19 Vax Issued EUA

      Phase 3 ENSEMBLE study demonstrated the vaccine was 85 percent effective in preventing severe disease.
      Kristin Brooks 03.01.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Celonic Group Announces Plans for New Facility in Switzerland

      Celonic Group Announces Plans for New Facility in Switzerland

      Will add up to 20 GMP clean room suites and offices along with laboratories.
      Charles Sternberg, Assistant Editor 03.01.21


    • Breaking News | Promotions & Moves
      Pii Promotes Monique Mendoza to Head of Quality

      Pii Promotes Monique Mendoza to Head of Quality

      Mendoza will be responsible for the entire Quality unit at Pii and report directly to Kurt Nielsen.
      Charles Sternberg, Assistant Editor 03.01.21

    • Breaking News | CRO News | Drug Discovery | Industry News | R&D
      Icon to Acquire PRA Health Sciences

      Icon to Acquire PRA Health Sciences

      Brings together two organizations to create a leading healthcare intelligence and clinical CRO.
      Charles Sternberg, Assistant Editor 03.01.21

    • Breaking News | Collaborations & Alliances | Industry News
      Phlow Corp. and USP Form Alliance

      Phlow Corp. and USP Form Alliance

      Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.
      Tim Wright, Editor, Contract Pharma 03.01.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      BMS Expands Cell Therapy Manufacturing Capabilities

      BMS Expands Cell Therapy Manufacturing Capabilities

      New state-of-the-art cell therapy manufacturing facility under construction to expand global footprint.
      Tim Wright, Editor, Contract Pharma 03.01.21

    • Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Novo Nordisk Invests $80M in Tablet Production

      Novo Nordisk Invests $80M in Tablet Production

      Expanding site in Måløv, Denmark that currently makes products for oral diabetes.
      Tim Wright, Editor, Contract Pharma 03.01.21

    • Aseptic Processing | Breaking News | Industry News
      Arcline Investment Acquires ChargePoint Technology

      Arcline Investment Acquires ChargePoint Technology

      Acquisition of pharma equipment specialist will empower company to support global customers in responding to fast-changing markets.
      Tim Wright, Editor, Contract Pharma 03.01.21

    Trending
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • Spark Therapeutics Appoints CTO
    • The Future Of Vaccines And Biologics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • Alimentiv Acquires McDougall Scientific
    • Q BioMed Inks Strontium89 Supply Pact
    • PCI Pharma Services Appoints SVP, CFO
    • AbbVie Opts to Acquire Mitokinin
    • WuXi AppTec Completes OXGENE Acquisition
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    IFS Coatings Breaks Ground on 70,000-Square-Foot Expansion
    Nouryon Agrees to Divest Salt Specialties Business to Salins Group
    PPG Appoints John Stephenson as Director, Acquisition Integration
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    Memic Receives FDA Marketing Authorization for Hominis
    Varian CEO to Retire Following Siemens Healthineers Acquisition
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Alimentiv Acquires McDougall Scientific
    Q BioMed Inks Strontium89 Supply Pact
    PCI Pharma Services Appoints SVP, CFO
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Inter Parfums Reports a Strong Fourth Quarter
    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Happi

    Latest Breaking News From Happi

    Sustainable Cosmetics Summit is Online in June
    Beiersdorf and Evonik Partner on Nature Conservation Project
    Jodie Foster Wears Biography Face Oil at the Golden Globes
    Ink World

    Latest Breaking News From Ink World

    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Maxcess launches Tidland PressureMax Airshaft Pressure Monitoring System
    CP Printing adds Colordyne 3800 Series AP – Retrofit
    Edale names SMAG Graphique distributor in France
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Domtar Completes Sale of Personal Care Business
    Mitsui to Sell Chinese Nonwovens Business
    Dr. J's Disinfectant Wipes Approved for Distribution in CA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Q-Collar Device Protect Athletes’ Brains During Head Impacts
    SeaSpine Releases Reef TO (TLIF Oblique) Interbody System
    Align Technology Inc. Executive Joins Zimmer Biomet Board
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login